• Las Vegas 12:34
  • NY Florida 12:34
September 22, 2022

CBD – A Superbug Bacteria Killer

Lab examines completed by experts at the University of Queensland’s Institute for Molecular Bioscience demonstrated that CBD could help in the worldwide battle to stop lethal superbugs. The discovery, which was a cooperation between IMB’s Center for Superbug Solutions and Botanix Pharmaceuticals Limited, could prompt the main new class of anti-toxins for safe microorganisms in 60 years. Dr Mark Blaskovich, Director of the Institute for Molecular Bioscience, said CBD can penetrate and execute a wide scope of microorganisms including Neisseria gonorrhoeae, which causes gonorrhea.

Blaskovich said: “This is the first time CBD has been shown to kill some types of Gram-negative bacteria. These bacteria have an extra outer membrane, an additional line of defence that makes it harder for antibiotics to penetrate.”

The news could be particularly huge for individuals in Australia, where gonorrhea is the second most normal sexually transmitted contamination. As indicated by IMB, it’s gotten regular to such an extent that there’s not, at this point a solitary dependable anti-infection to treat it, as the microbes is especially acceptable at creating obstruction.

The study – which was as of late distributed in the Communications Biology diary – likewise proposed cannabidiol is powerful in killing superbug MRSA found in brilliant staph microscopic organisms, and might be utilized to treat diabetic ulcers and wounds.

Credit: Institute for Molecular Bioscience

“Cannabidiol showed a low tendency to cause resistance in bacteria even when we sped up potential development by increasing concentrations of the antibiotic during ‘treatment’,” Blaskovich added.

“We think that cannabidiol kills bacteria by bursting their outer cell membranes, but we don’t know yet exactly how it does that, and need to do further research.”

Vince Ippolito, the President and Executive Chairman of Botanix, said the research showed enormous potential for the advancement of powerful medicines to handle the developing worldwide danger of anti-toxin opposition.

Ippolito said: “Congratulations to Dr Blaskovich and his team for producing this significant body of research – the published data clearly establishes the potential of synthetic cannabinoids as antimicrobials.”

Further trials of CBD formulations are now underway, with Blaskovich telling the Courier Mail: “We think we can engineer a different version of CBD that will be able to have some systemic activity.

“We want something that doesn’t break down in the body as quickly as CBD does. There’s definitely potential there that CBD could be a prototypical representative of a new class of antibiotics.”

Blaskovich said: “This is the first time CBD has been shown to kill some types of Gram-negative bacteria. These bacteria have an extra outer membrane, an additional line of defence that makes it harder for antibiotics to penetrate.”

The news could be particularly huge for individuals in Australia, where gonorrhea is the second most normal sexually transmitted contamination. As indicated by IMB, it’s gotten regular to such an extent that there’s not, at this point a solitary dependable anti-infection to treat it, as the microbes is especially acceptable at creating obstruction.

The study – which was as of late distributed in the Communications Biology diary – likewise proposed cannabidiol is powerful in killing superbug MRSA found in brilliant staph microscopic organisms, and might be utilized to treat diabetic ulcers and wounds.

 

Facebook
Twitter
LinkedIn
WhatsApp

Leave a Comment

Your email address will not be published.

Skip to content